Wonbeak Yoo

1.0k total citations
29 papers, 752 citations indexed

About

Wonbeak Yoo is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Wonbeak Yoo has authored 29 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Wonbeak Yoo's work include Liver Disease Diagnosis and Treatment (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Ferroptosis and cancer prognosis (3 papers). Wonbeak Yoo is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Ferroptosis and cancer prognosis (3 papers). Wonbeak Yoo collaborates with scholars based in South Korea, United States and Mexico. Wonbeak Yoo's co-authors include Kyung Hee Noh, Jing Wang, Heather L. Stevenson, Hong Shen, Laura Beretta, George Kunos, Jong‐Min Jeong, Bin Gao, Soo Jin Kim and Suk-Jo Kang and has published in prestigious journals such as Nature Communications, PLoS ONE and Nature Cell Biology.

In The Last Decade

Wonbeak Yoo

28 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wonbeak Yoo South Korea 15 275 199 151 141 88 29 752
Jae Kwang Kim South Korea 18 345 1.3× 166 0.8× 179 1.2× 100 0.7× 68 0.8× 44 851
Jinghua Jiang China 18 334 1.2× 177 0.9× 154 1.0× 121 0.9× 56 0.6× 41 858
Marta Benet Spain 13 633 2.3× 273 1.4× 117 0.8× 77 0.5× 88 1.0× 26 1.1k
Jerzy Kotlinowski Poland 16 657 2.4× 183 0.9× 84 0.6× 96 0.7× 87 1.0× 39 1.0k
Jin Ye China 18 446 1.6× 245 1.2× 120 0.8× 90 0.6× 211 2.4× 63 1.0k
Xueke Zhao China 20 522 1.9× 321 1.6× 141 0.9× 105 0.7× 66 0.8× 58 1.2k
Qinggao Zhang China 20 404 1.5× 116 0.6× 131 0.9× 243 1.7× 99 1.1× 51 919
Adisak Wongkajornsilp Thailand 20 250 0.9× 93 0.5× 128 0.8× 227 1.6× 221 2.5× 52 1.1k
Yoshinobu Saito Japan 14 283 1.0× 409 2.1× 57 0.4× 81 0.6× 54 0.6× 34 754
Wensong Ge China 12 374 1.4× 222 1.1× 50 0.3× 171 1.2× 39 0.4× 30 822

Countries citing papers authored by Wonbeak Yoo

Since Specialization
Citations

This map shows the geographic impact of Wonbeak Yoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wonbeak Yoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wonbeak Yoo more than expected).

Fields of papers citing papers by Wonbeak Yoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wonbeak Yoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wonbeak Yoo. The network helps show where Wonbeak Yoo may publish in the future.

Co-authorship network of co-authors of Wonbeak Yoo

This figure shows the co-authorship network connecting the top 25 collaborators of Wonbeak Yoo. A scholar is included among the top collaborators of Wonbeak Yoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wonbeak Yoo. Wonbeak Yoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noh, Kyunghee, Hye-Ran Kim, Ji Eun Lee, et al.. (2025). Targeting CD155 in lung adenocarcinoma: A5 nanobody-based therapeutics for precision treatment and enhanced drug delivery. Signal Transduction and Targeted Therapy. 10(1). 218–218. 1 indexed citations
2.
Yoo, Wonbeak, Hyun‐Ji Choi, Dana Jung, et al.. (2025). Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancer. Cancer Immunology Immunotherapy. 74(2). 73–73. 4 indexed citations
3.
Yoo, Wonbeak, et al.. (2024). CRHBP, a novel multiple cancer biomarker connected with better prognosis and anti-tumorigenicity. Cancer Cell International. 24(1). 391–391. 1 indexed citations
4.
Yoo, Wonbeak, et al.. (2024). Comprehensive analysis on clinical significance and therapeutic targets of LDL receptor related protein 11 (LRP11) in liver hepatocellular carcinoma. Frontiers in Pharmacology. 15. 1338929–1338929. 2 indexed citations
5.
Noh, Kyunghee, et al.. (2024). Role of SYT11 in human pan-cancer using comprehensive approaches. European journal of medical research. 29(1). 338–338.
6.
Lee, Eun Jeoung, Sol Lee, Hyun‐Jae Jang, & Wonbeak Yoo. (2023). Loliolide in Sargassum horneri Alleviates Ultrafine Urban Particulate Matter (PM 0.1)-Induced Inflammation in Human RPE Cells. International Journal of Molecular Sciences. 25(1). 162–162. 2 indexed citations
7.
Yoo, Wonbeak, Seokho Kim, & Kyunghee Noh. (2023). SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma. European journal of medical research. 28(1). 514–514. 2 indexed citations
8.
Yoo, Wonbeak, Wonhwa Lee, Hong Nam Kim, et al.. (2022). Nanodiamond as a Cytokine Sponge in Infectious Diseases. Frontiers in Bioengineering and Biotechnology. 10. 862495–862495. 9 indexed citations
9.
Yoo, Wonbeak, Hyun‐Ji Choi, Young Hoon Son, et al.. (2021). Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor. Experimental & Molecular Medicine. 53(3). 432–445. 14 indexed citations
10.
Sanai, Nader, K Hendrickson, Jennifer Eschbacher, et al.. (2021). 347MO 5-Aminolevulinic acid sonodynamic therapy in recurrent glioblastoma: A first-in-human phase 0/1 clinical trial. Annals of Oncology. 32. S518–S519. 1 indexed citations
11.
Jeong, Jin‐Yong, Tae‐Bum Kim, Jinju Kim, et al.. (2020). Diversity in the Extracellular Vesicle-Derived Microbiome of Tissues According to Tumor Progression in Pancreatic Cancer. Cancers. 12(9). 2346–2346. 28 indexed citations
12.
Li, Hua, Wonbeak Yoo, Hye‐Mi Park, et al.. (2019). Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model. International Journal of Molecular Sciences. 20(9). 2325–2325. 11 indexed citations
13.
Yoo, Wonbeak, Jaemin Lee, Kyung Hee Noh, et al.. (2019). Progranulin attenuates liver fibrosis by downregulating the inflammatory response. Cell Death and Disease. 10(10). 758–758. 45 indexed citations
14.
Jung, Kwang Hwa, Wonbeak Yoo, Heather L. Stevenson, et al.. (2017). Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice. Clinical Cancer Research. 23(18). 5537–5546. 98 indexed citations
15.
Yoo, Wonbeak, Heather L. Stevenson, Xiaoling Song, et al.. (2017). Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid. PLoS ONE. 12(12). e0189965–e0189965. 49 indexed citations
16.
Kim, So Yeon, Jong‐Min Jeong, Soo Jin Kim, et al.. (2017). Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4–MD2 complex. Nature Communications. 8(1). 2247–2247. 210 indexed citations
17.
Lee, Hong Sik, Sangeun Park, Wonbeak Yoo, et al.. (2015). Fusion protein of retinol‐binding protein and albumin domain III reduces liver fibrosis. EMBO Molecular Medicine. 7(6). 819–830. 24 indexed citations
18.
Yoo, Wonbeak, Kyung Hee Noh, Jae Hee Ahn, et al.. (2014). HIF‐1α Expression as a Protective Strategy of HepG2 Cells Against Fatty Acid‐Induced Toxicity. Journal of Cellular Biochemistry. 115(6). 1147–1158. 35 indexed citations
19.
Yoo, Wonbeak, et al.. (2010). Albumin expression is required for adipocyte differentiation of 3T3-L1 cells. Biochemical and Biophysical Research Communications. 397(2). 170–175. 15 indexed citations
20.
Yoo, Wonbeak, et al.. (2007). P2-033: Polymorphisms of Jak3 contribute to diminished promoter activity and increased risk of lung cancer in Korea populations. Journal of Thoracic Oncology. 2(8). S495–S495. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026